353 related articles for article (PubMed ID: 15552932)
1. [Urinary 8-hydroxy-2'-deoxyguanosin (8-OHdG) in patients with chronic liver diseases].
Ishizakai M; Yoshida K; Nishimoto N; Saleh AM; Ishii C; Handa H; Ogawara H; Nagamine T; Murakami M; Murakami H
Rinsho Byori; 2004 Sep; 52(9):732-6. PubMed ID: 15552932
[TBL] [Abstract][Full Text] [Related]
2. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.
Fujita N; Sugimoto R; Ma N; Tanaka H; Iwasa M; Kobayashi Y; Kawanishi S; Watanabe S; Kaito M; Takei Y
J Viral Hepat; 2008 Jul; 15(7):498-507. PubMed ID: 18331251
[TBL] [Abstract][Full Text] [Related]
3. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.
Xu GW; Yao QH; Weng QF; Su BL; Zhang X; Xiong JH
J Pharm Biomed Anal; 2004 Sep; 36(1):101-4. PubMed ID: 15351053
[TBL] [Abstract][Full Text] [Related]
4. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
[TBL] [Abstract][Full Text] [Related]
5. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
6. Significance of the urinary 8-OHdG level as an oxidative stress marker in lung cancer patients.
Yano T; Shoji F; Baba H; Koga T; Shiraishi T; Orita H; Kohno H
Lung Cancer; 2009 Jan; 63(1):111-4. PubMed ID: 18676055
[TBL] [Abstract][Full Text] [Related]
7. Significance of urinary excretion of 8-hydroxy-2'-deoxyguanosine in healthy subjects and liver disease patients.
Ichiba M; Yamada S; Ishii K; Gonda K; Murai R; Shimomura T; Saeki T; Kanbe T; Tanabe Y; Yoshida Y; Tsuchiya H; Hoshikawa Y; Kurimasa A; Kishimoto Y; Kawasaki H; Shiota G
Hepatogastroenterology; 2007 Sep; 54(78):1736-40. PubMed ID: 18019707
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of oxidative DNA damage in children with brain damage using 8-hydroxydeoxyguanosine levels.
Fukuda M; Yamauchi H; Yamamoto H; Aminaka M; Murakami H; Kamiyama N; Miyamoto Y; Koitabashi Y
Brain Dev; 2008 Feb; 30(2):131-6. PubMed ID: 17766071
[TBL] [Abstract][Full Text] [Related]
9. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
[TBL] [Abstract][Full Text] [Related]
10. Increased salivary level of 8-hydroxydeoxyguanosine is a marker of premature oxidative mitochondrial DNA damage in gingival tissue of patients with periodontitis.
Canakçi CF; Canakçi V; Tatar A; Eltas A; Sezer U; Ciçek Y; Oztas S
Arch Immunol Ther Exp (Warsz); 2009; 57(3):205-11. PubMed ID: 19479201
[TBL] [Abstract][Full Text] [Related]
11. Circadian variation in multiple sclerosis of oxidative stress marker of DNA damage. A potential cancer marker?
Kanabrocki EL; Ryan MD; Murray D; Jacobs RW; Wang J; Hurder A; Friedman NC; Siegel G; Eladasari B; Nemchausky BA; Cornelissen G; Halberg F
Clin Ter; 2006; 157(2):117-22. PubMed ID: 16817500
[TBL] [Abstract][Full Text] [Related]
12. Association of oxidative stress with arsenic methylation in chronic arsenic-exposed children and adults.
Xu Y; Wang Y; Zheng Q; Li X; Li B; Jin Y; Sun X; Sun G
Toxicol Appl Pharmacol; 2008 Oct; 232(1):142-9. PubMed ID: 18640141
[TBL] [Abstract][Full Text] [Related]
13. Urinary 8-hydroxy-2'-deoxyguanosine excretion as a biomarker for estimating DNA oxidation in patients undergoing external radiotherapy and/or brachytherapy.
Yamazaki H; Inoue T; Koizumi M; Tanaka E; Yoshioka Y; Nakamura H; Shuo X; Inoue T
Oncol Rep; 2005 May; 13(5):847-51. PubMed ID: 15809748
[TBL] [Abstract][Full Text] [Related]
14. Effect of short-term fasting on urinary excretion of primary lipid peroxidation products and on markers of oxidative DNA damage in healthy women.
Lee KH; Bartsch H; Nair J; Yoo DH; Hong YC; Cho SH; Kang D
Carcinogenesis; 2006 Jul; 27(7):1398-403. PubMed ID: 16401636
[TBL] [Abstract][Full Text] [Related]
15. Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area.
Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
Toxicol Appl Pharmacol; 2008 Jan; 226(1):14-21. PubMed ID: 17950770
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid monotherapy induces DNA oxidative damage.
Schulpis KH; Lazaropoulou C; Regoutas S; Karikas GA; Margeli A; Tsakiris S; Papassotiriou I
Toxicology; 2006 Jan; 217(2-3):228-32. PubMed ID: 16289809
[TBL] [Abstract][Full Text] [Related]
17. Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease.
Sato S; Mizuno Y; Hattori N
Neurology; 2005 Mar; 64(6):1081-3. PubMed ID: 15781836
[TBL] [Abstract][Full Text] [Related]
18. Oxidative DNA damage in patients with prostate cancer and its response to treatment.
Miyake H; Hara I; Kamidono S; Eto H
J Urol; 2004 Apr; 171(4):1533-6. PubMed ID: 15017214
[TBL] [Abstract][Full Text] [Related]
19. Increased urinary 8-hydroxy-2'-deoxyguanosine excretion in long-distance bus drivers in Taiwan.
Han YY; Donovan M; Sung FC
Chemosphere; 2010 May; 79(9):942-8. PubMed ID: 20303570
[TBL] [Abstract][Full Text] [Related]
20. Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet.
Kato J; Kobune M; Nakamura T; Kuroiwa G; Takada K; Takimoto R; Sato Y; Fujikawa K; Takahashi M; Takayama T; Ikeda T; Niitsu Y
Cancer Res; 2001 Dec; 61(24):8697-702. PubMed ID: 11751387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
